Nureca Limited , a company listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), has announced that its Board of Directors will consider a proposal for the buyback of equity shares. This corporate action is set to be discussed at a board meeting scheduled for November 10, 2025.

Key Details of the Announcement

Regulatory Compliance

The company has adhered to regulatory requirements by informing both the BSE and NSE about this agenda item. This disclosure aligns with Regulation 29(1)(b) of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Implications for Shareholders

If approved, a buyback could have several implications for Nureca's shareholders:

1. Potential increase in earnings per share
2. Possible positive impact on the stock price
3. Opportunity for shareholders to tender their shares

It's important to note that the board meeting will only consider the buyback proposal. The final decision, including details such as the buyback size, price, and method, will be subject to board approval and subsequent regulatory processes.

Company Information

Nureca Limited, with its registered office in Mumbai and correspondence office in Chandigarh, operates under the Corporate Identification Number (CIN) L24304MH2016PLC320868. The company has made this information available on its official website, www.nureca.com , ensuring transparency in its communications with stakeholders.

Investors and market participants are advised to await the outcome of the board meeting for further details on the potential buyback. As always, it's recommended to consult with financial advisors before making any investment decisions based on this development.

Nureca Limited , a prominent player in the home healthcare and wellness sector, has received a significant regulatory green light from the Securities and Exchange Board of India (SEBI). The company announced that SEBI has granted approval for an exemption from Regulation 24(ii) of the Buy-Back Regulations, allowing Nureca to proceed with a share buyback while its merger scheme with wholly-owned subsidiary Nureca Technologies Private Limited is pending before the National Company Law Tribunal (NCLT).

Key Developments

• SEBI Approval: Granted
• Merger Scheme Approval: Board approved on May 20; Shareholders approved on June 16
• Merger Type: Internal restructuring involving no new equity issuance or change in shareholding pattern
• Buyback Participation: Promoters have committed not to participate, making it exclusive for public shareholders

Regulatory Context

The exemption granted by SEBI is from Regulation 24(ii) of the SEBI (Buy-Back of Securities) Regulations, 2018, which typically prohibits companies from announcing buybacks during pending schemes of arrangement. SEBI's decision to grant this exemption considers the nature of the merger as an internal restructuring that does not affect the company's public shareholding.

Implications for Shareholders

This development is particularly significant for Nureca's public shareholders. With the promoters abstaining from the buyback, the opportunity is exclusively available to public shareholders, potentially offering them an avenue to realize value in the near term.

Next Steps

Nureca's board of directors will consider the buyback proposal at an appropriate time. The company has assured compliance with all applicable regulations throughout the process.

Market Perspective

This move by Nureca Limited demonstrates a strategic approach to capital management while navigating regulatory requirements. The ability to proceed with a share buyback during a pending merger reflects the company's focus on shareholder value and its confidence in its financial position.

As the home healthcare and wellness sector continues to evolve, Nureca's actions may be indicative of broader trends in corporate strategy within the industry, balancing growth initiatives with shareholder returns.

Investors are advised to monitor further announcements from Nureca Limited regarding the specifics of the buyback program and the progress of the merger with Nureca Technologies Private Limited.